HealthEquity Inc Forecast, price target & analysts
HealthEquity Inc Target price 2025 - Analyst rating & recommendation
HealthEquity Inc Classifications & Recommendation:
HealthEquity Inc Price Target
| Target Price | $112.36 |
| Price | $82.97 |
| Potential |
35.42%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target HealthEquity Inc 2026 .
The average HealthEquity Inc target price is $112.36.
This is
35.42%
register free of charge
$130.00
56.68%
register free of charge
$94.00
13.29%
register free of charge
|
|
| A rating was issued by 15 analysts: 14 Analysts recommend HealthEquity Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the HealthEquity Inc stock has an average upside potential 2026 of
35.42%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Jan '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.20 | 1.30 |
| 20.03% | 8.54% | |
| EBITDA Margin | 32.72% | 41.08% |
| 16.29% | 25.56% | |
| Net Margin | 7.86% | 12.34% |
| 41.90% | 56.95% |
14 Analysts have issued a sales forecast HealthEquity Inc 2026 . The average HealthEquity Inc sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an HealthEquity Inc EBITDA forecast 2026. The average HealthEquity Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 HealthEquity Inc Analysts have issued a net profit forecast 2026. The average HealthEquity Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Jan '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.09 | 1.86 |
| 70.31% | 70.64% | |
| P/E | 44.69 | |
| EV/Sales | 6.14 |
10 Analysts have issued a HealthEquity Inc forecast for earnings per share. The average HealthEquity Inc EPS is
This results in the following potential growth metrics and future valuations:
HealthEquity Inc...
Current HealthEquity Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Mar 27 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
| Barrington Research |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
| Barrington Research |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Feb 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Mar 27 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Mar 24 2025 |
|
Locked
Barrington Research:
Locked
➜
Locked
|
Mar 19 2025 |
|
Locked
Barrington Research:
Locked
➜
Locked
|
Mar 14 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 26 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Feb 25 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
